Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp
- 1 January 2010
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (1), 52-56
- https://doi.org/10.1128/jcm.01590-09
Abstract
We tested a global collection of Candida sp. strains against anidulafungin, caspofungin, and micafungin, using CLSI M27-A3 broth microdilution (BMD) methods, in order to define wild-type (WT) populations and epidemiological cutoff values (ECVs). From 2003 to 2007, 8,271 isolates of Candida spp. (4,283 C. albicans , 1,236 C. glabrata , 1,238 C. parapsilosis , 996 C. tropicalis , 270 C. krusei , 99 C. lusitaniae , 88 C. guilliermondii , and 61 C. kefyr isolates) were obtained from over 100 centers worldwide. The modal MICs (in μg/ml) for anidulafungin, caspofungin, and micafungin, respectively, for each species were as follows: C. albicans , 0.03, 0.03, 0.015; C. glabrata , 0.06, 0.03, 0.015; C. tropicalis , 0.03, 0.03, 0.015; C. kefyr , 0.06, 0.015, 0.06; C. krusei , 0.03, 0.06, 0.06; C. lusitaniae , 0.05, 0.25, 0.12; C. parapsilosis , 2, 0.25, 1; and C. guilliermondii , 2, 0.5. 05. The ECVs, expressed in μg/ml (percentage of isolates that had MICs that were less than or equal to the ECV is shown in parentheses) for anidulafungin, caspofungin, and micafungin, respectively, were as follows: 0.12 (99.7%), 0.12 (99.8%), and 0.03 (97.7%) for C. albicans ; 0.25 (99.4%), 0.12 (98.5%), and 0.03 (98.2%) for C. glabrata ; 0.12 (98.9%), 0.12 (99.4%), and 0.12 (99.1%) for C. tropicalis ; 0.25(100%), 0.03 (100%), and 0.12 (100%) for C. kefyr ; 0.12 (99.3%), 0.25 (96.3%), and 0.12 (97.8%) for C. krusei ; 2 (100%), 0.5 (98.0%), and 0.5 (99.0%) for C. lusitaniae ; 4 (100%), 1 (98.6%), and 4 (100%) for C. parapsilosis ; 16 (100%), 4 (95.5%), and 4 (98.9%) for C. guilliermondii . These WT MIC distributions and ECVs will be useful in surveillance for emerging reduced echinocandin susceptibility among Candida spp. and for determining the importance of various FKS1 or other mutations.Keywords
This publication has 27 references indexed in Scilit:
- Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β- d -Glucan Synthase: Implication for the Existing Susceptibility BreakpointAntimicrobial Agents and Chemotherapy, 2009
- Breakpoints for Susceptibility Testing Should Not Divide Wild-Type Distributions of Important Target SpeciesAntimicrobial Agents and Chemotherapy, 2009
- Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans : Implications for Interpretive BreakpointsAntimicrobial Agents and Chemotherapy, 2009
- Pyrosequencing To Detect Mutations in FKS1 That Confer Reduced Echinocandin Susceptibility in Candida albicansAntimicrobial Agents and Chemotherapy, 2008
- Caspofungin-Resistant Candida tropicalis Strains Causing Breakthrough Fungemia in Patients at High Risk for Hematologic MalignanciesAntimicrobial Agents and Chemotherapy, 2008
- Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata InfectionAntimicrobial Agents and Chemotherapy, 2008
- Mutations in the fks1 Gene in Candida albicans , C. tropicalis , and C. krusei Correlate with Elevated Caspofungin MICs Uncovered in AM3 Medium Using the Method of the European Committee on Antibiotic Susceptibility TestingAntimicrobial Agents and Chemotherapy, 2008
- Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC BreakpointsJournal of Clinical Microbiology, 2008
- Setting and Revising Antibacterial Susceptibility BreakpointsClinical Microbiology Reviews, 2007
- Global Surveillance of In Vitro Activity of Micafungin against Candida : a Comparison with Caspofungin by CLSI-Recommended MethodsJournal of Clinical Microbiology, 2006